MarketCap
Facebook
X
Telegram
Merck & Co. EV/EBITDA | MRK
EV/EBITDA Jährlich Merck & Co.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97.3 | 103 | 175 | 146 | 117 | 108 | 14.2 | 14.8 | 14.6 | 15.6 | 11 | 13.3 | 10.8 | 7.88 | 7.12 | 11.9 | 19.5 | 45 | -2.68 | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 175 | -2.68 | 48.9 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 2.3 | -5.35 % | $ 14.7 B |  Australia |
 |
Shineco, Inc.
TYHT
|
3.76 | - | -3.90 % | $ 97.2 M |  China |
 |
Millendo Therapeutics, Inc.
MLND
|
1.01 | - | -5.36 % | $ 20.2 M |  USA |
 |
Certara
CERT
|
14.4 | $ 12.21 | -0.08 % | $ 1.96 B | USA |
 |
Dyadic International
DYAI
|
-4.95 | $ 0.39 | 1.16 % | $ 14.1 M | USA |
 |
Intec Pharma Ltd
NTEC
|
-0.115 | - | -12.45 % | $ 17.7 M |  Israel |
 |
Anika Therapeutics
ANIK
|
-27.5 | $ 13.42 | -7.89 % | $ 192 M | USA |
 |
Aprea Therapeutics
APRE
|
0.729 | $ 0.45 | -9.44 % | $ 2.94 M | USA |
 |
Galectin Therapeutics
GALT
|
-15.3 | $ 3.4 | -1.73 % | $ 217 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
83.2 | $ 73.22 | -2.41 % | $ 7.6 B | USA |
 |
Progenity, Inc.
PROG
|
-2.15 | - | -3.47 % | $ 164 M | USA |
 |
Genprex
GNPX
|
0.257 | $ 2.1 | 1.94 % | $ 1.96 M | USA |
 |
Strongbridge Biopharma plc
SBBP
|
-2.13 | - | 1.52 % | $ 136 M | USA |
 |
Innate Pharma S.A.
IPHA
|
-1.82 | $ 1.54 | 1.98 % | $ 138 M |  France |
 |
Seneca Biopharma, Inc.
SNCA
|
0.944 | - | -1.19 % | $ 28.7 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
24.3 | $ 57.1 | -0.14 % | $ 11 B | USA |
 |
Matinas BioPharma Holdings
MTNB
|
-0.161 | $ 1.19 | -4.03 % | $ 6.51 M | USA |
 |
Enanta Pharmaceuticals
ENTA
|
-2.28 | $ 11.24 | -2.01 % | $ 240 K | USA |
 |
SIGA Technologies
SIGA
|
11.1 | $ 3.14 | -3.83 % | $ 225 M | USA |
 |
Milestone Pharmaceuticals
MIST
|
-2.31 | $ 0.68 | -7.49 % | $ 72.2 M |  Canada |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
42 | $ 94.9 | -3.91 % | $ 7.04 B | USA |
 |
Lipocine
LPCN
|
-1.47 | $ 1.59 | -7.85 % | $ 8.66 M | USA |
 |
PTC Therapeutics
PTCT
|
8.48 | $ 64.12 | -1.4 % | $ 5.1 B | USA |
 |
Seres Therapeutics
MCRB
|
-1.23 | $ 1.55 | -8.75 % | $ 13.7 M | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
-34.7 | $ 432.48 | -0.07 % | $ 9.7 B | USA |
 |
CEL-SCI Corporation
CVM
|
-0.928 | $ 1.41 | 4.07 % | $ 11.3 M | USA |
 |
Inventiva S.A.
IVA
|
-3.2 | $ 3.95 | 2.73 % | $ 236 M | France |
 |
MeiraGTx Holdings plc
MGTX
|
-8.94 | $ 9.62 | 1.37 % | $ 774 M | USA |
 |
Processa Pharmaceuticals
PCSA
|
-0.0598 | $ 1.86 | -4.62 % | $ 2.44 M | USA |
 |
Eton Pharmaceuticals
ETON
|
187 | $ 67.5 | 4.9 % | $ 1.82 B | USA |
 |
IDEAYA Biosciences
IDYA
|
-17.2 | $ 31.72 | -0.97 % | $ 2.81 B | USA |
 |
Protalix BioTherapeutics
PLX
|
-47.8 | $ 2.86 | 11.28 % | $ 225 M | Israel |
 |
Lantern Pharma
LTRN
|
-0.757 | $ 0.47 | -22.86 % | $ 5.12 M | USA |
 |
Foghorn Therapeutics
FHTX
|
-7 | $ 1.89 | -7.35 % | $ 119 M | USA |
 |
Ocugen
OCGN
|
-10.8 | $ 0.95 | -2.45 % | $ 297 M | USA |
 |
Oncolytics Biotech
ONCY
|
-1.33 | $ 0.38 | -5.64 % | $ 36.4 M | Canada |
 |
Minerva Neurosciences
NERV
|
-14.1 | $ 2.47 | -6.08 % | $ 20.9 M | USA |
 |
Kamada Ltd.
KMDA
|
15.8 | $ 8.09 | 4.93 % | $ 466 M | Israel |
 |
Neurocrine Biosciences
NBIX
|
1.03 | $ 169.08 | 0.13 % | $ 16.8 B | USA |
 |
Nanobiotix S.A.
NBTX
|
-134 K | $ 32.8 | 2.4 % | $ 1.57 T | France |
 |
Mereo BioPharma Group plc
MREO
|
-16.6 | $ 0.3 | 1.66 % | $ 239 M |  Britain |
 |
Maravai LifeSciences Holdings
MRVI
|
-2.55 | $ 7.86 | -2.31 % | $ 1.13 B | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
-13.1 | $ 1.84 | 0.82 % | $ 668 M | USA |
 |
Moleculin Biotech
MBRX
|
-0.0282 | $ 8.01 | -7.51 % | $ 9.49 M | USA |
 |
Nurix Therapeutics
NRIX
|
-5.31 | $ 15.89 | -1.58 % | $ 1.38 B | USA |
 |
Nkarta
NKTX
|
-1.86 | $ 1.36 | -14.78 % | $ 101 M | USA |
 |
MacroGenics
MGNX
|
-4.46 | $ 2.42 | 3.42 % | $ 153 M | USA |
 |
Protagonist Therapeutics
PTGX
|
-34.8 | $ 136.18 | 0.2 % | $ 8.66 B | USA |
|
Nuvation Bio
NUVB
|
-10 | $ 4.22 | -3.1 % | $ 1.44 B | USA |
 |
Novo Nordisk A/S
NVO
|
3.62 | $ 40.6 | -1.88 % | $ 180 B |  Danmark |